Background: The optimal surgical technique for primary inguinal hernia repair remains debated, particularly concerning the use of synthetic mesh versus tissue-based approaches. This study compared the clinical efficacy, safety, cost-effectiveness, and long-term outcomes of Desarda’s no-mesh tissue repair with the standard Lichtenstein mesh repair. Methods: In this prospective, randomised, comparative study, 152 adult patients with primary, reducible inguinal or inguino-scrotal hernia were enrolled at a tertiary care centre in India and randomised to undergo either Desarda repair (n=76) or Lichtenstein mesh repair (n=76). Perioperative, short-term, economic, and long-term outcomes were recorded, including operative time, postoperative pain (VAS, day 1), ambulation time, wound complications, hospital stay, total cost, recurrence, and chronic pain at 3, 6, and 12 months. Statistical analysis was performed using t-tests, Mann–Whitney U, Fisher’s exact test, and Kaplan–Meier analysis. Results: The mean operative time was significantly longer for Desarda (55.7 ± 12.1 min) than for Lichtenstein (50.6 ± 12.5 min; p < 0.001). Postoperative pain scores on day 1 were significantly lower in the Desarda group (3.8 ± 1.2 vs. 4.6 ± 1.3; p = 0.0002), and ambulation occurred earlier (10.8 ± 3.7 hr vs. 13.2 ± 3.9 hr; p < 0.001). Wound infection and induration rates were low and not significantly different between groups. Hospital stay was modestly but significantly shorter in the Desarda group (3.1 ± 0.8 vs. 3.4 ± 0.8 days; p = 0.01). The total cost was substantially lower for Desarda (₹5,750 ± 780) than Lichtenstein (₹8,320 ± 1,350; p < 0.001). Recurrence rates at 12 months were low and comparable (3% vs. 4%, p = 1.00). Chronic pain or discomfort was infrequent in both groups. Conclusion: Desarda’s no-mesh repair is a safe and effective alternative to Lichtenstein mesh repair for primary inguinal hernia, offering advantages of reduced postoperative pain, earlier ambulation, shorter hospital stay, and lower cost, without increasing recurrence or complication rates. Both techniques remain viable options for surgical management, with individualisation based on patient preference and resource availability.
Inguinal hernia remains one of the most common general surgical conditions worldwide, with a substantial impact on quality of life and health care systems. The ideal surgical approach for primary inguinal hernia repair continues to be a subject of active debate, particularly regarding the use of prosthetic mesh versus tissue-based techniques【1】. The Lichtenstein mesh repair, introduced in the late twentieth century, is widely regarded as the standard of care due to its simplicity, reproducibility, and low recurrence rates. However, mesh-related complications such as chronic groin pain, foreign body sensation, and infection remain notable concerns, motivating renewed interest in alternative techniques【2】.
The Desarda technique, a no-mesh, tension-free tissue repair utilising a strip of external oblique aponeurosis to reinforce the posterior wall of the inguinal canal, has emerged as a promising alternative. Several prospective studies and clinical trials have reported that Desarda’s method may offer comparable recurrence rates to mesh repair, while potentially reducing postoperative pain and eliminating mesh-associated risks【3】【4】. As a result, Desarda’s repair has gained particular traction in regions with limited resources, as well as among patients preferring to avoid synthetic implants.
Despite a growing body of literature, direct comparative data between Desarda and Lichtenstein repairs remain limited, particularly with respect to postoperative recovery, complication rates, cost-effectiveness, and long-term outcomes. Some recent prospective studies suggest that the no-mesh approach is associated with earlier ambulation, lower early postoperative pain, and similar recurrence rates, but these findings are not yet universally accepted and debate persists regarding the optimal surgical technique【5】【6】.
This study aims to address this gap by prospectively comparing perioperative, short-term, economic, and long-term outcomes between Desarda’s tissue-based repair and the Lichtenstein mesh repair in adults with primary inguinal hernia. The results are intended to inform surgical practice and guide evidence-based decision-making for both surgeons and patients.
Objectives
The primary objective of this study was to compare the clinical outcomes of Desarda’s no-mesh tissue-based repair and the standard Lichtenstein mesh repair in adult patients with primary inguinal hernia.
The secondary objectives were:
Study Design and Setting
This prospective, randomised, comparative study was conducted in the Department of General Surgery at North 24 Parganas District Hospital, Barasat, West Bengal, India, between January 2016 and October 2016, with a follow-up period of 12 months post-surgery.
Study Population
Inclusion criteria:
Exclusion criteria:
Sample Size and Randomisation
The sample size was determined using estimates from previous randomised controlled trials, with 76 patients assigned to each group. Randomisation was accomplished using a computer-generated random number table and sequentially numbered, opaque, sealed envelopes. Allocation was revealed by the operating surgeon immediately prior to surgery.
Surgical Procedures
Perioperative Management
All patients underwent standard preoperative evaluation (clinical assessment, laboratory tests, ECG, chest X-ray, and abdominal ultrasonography). Premedication with midazolam and single-dose antibiotic prophylaxis were given. Anaesthesia (regional or general) was selected according to patient and anaesthetist preference.
Outcome Measures
Short-term outcomes:
Long-term outcomes:
Data Collection
Clinical data were recorded using a structured proforma covering demographics, clinical history, examination, investigations, intraoperative findings, and postoperative outcomes. Data were entered into Microsoft Excel and analysed with SPSS v21.0.
Statistical Analysis
Continuous variables are presented as mean ± standard deviation (SD) or median (interquartile range) as appropriate. Categorical variables are expressed as counts and percentages. The Kolmogorov–Smirnov test was used to assess normality. Student’s t-test was used for normally distributed continuous variables; the Mann–Whitney U test was used for non-normally distributed variables. Categorical data were compared using Fisher’s exact test. Kaplan–Meier analysis was performed for recurrence-free survival. A p-value <0.05 was considered statistically significant.
Ethical Considerations
The study received approval from the Institutional Ethics Committee of R.G. Kar Medical College, Kolkata. Written informed consent was obtained from all participants before enrolment.
A total of 152 patients with primary, reducible inguinal or inguino-scrotal hernia were enrolled and randomised: 76 assigned to the Desarda (no mesh) group and 76 to the Lichtenstein (mesh) group. All participants completed the index procedure and were included in the perioperative and short-term analyses. Follow-up rates at 12 months were high, with only minor loss to follow-up due to missing data.
Table 1. Baseline Demographic and Clinical Characteristics by Group
Variable |
Desarda (n=76) |
Lichtenstein (n=76) |
p-value |
Age (years) |
48.5 ± 13.4 (18–79) |
46.6 ± 14.0 (18–82) |
0.36 (t-test) |
Male gender |
72 (95%) |
70 (92%) |
0.74 (Fisher) |
Unilateral inguinal |
59 (78%) |
60 (79%) |
1.00 (Fisher) |
Bilateral inguinal |
7 (9%) |
7 (9%) |
1.00 (Fisher) |
Unilat. inguino-scrotal |
10 (13%) |
9 (12%) |
1.00 (Fisher) |
Operative Time
The mean operative time was 55.7 ± 12.1 minutes for the Desarda group and 50.6 ± 12.5 minutes for the Lichtenstein group. This difference was statistically significant (p < 0.001, independent t-test), with the mesh-based repair requiring less operative time on average. The range of operative times was 32–90 minutes for Desarda and 30–89 minutes for Lichtenstein, reflecting case-to-case variability and some procedural overlap between techniques.
Intraoperative Findings
No major intraoperative complications (such as vascular or visceral injury) were reported in either group. Intraoperative exclusion (due to weak or unsuitable external oblique aponeurosis) accounted for three cases, as outlined in the participant flow.
The Lichtenstein mesh repair was associated with a modestly but significantly shorter operative time, while the tissue-based Desarda technique required more time on average. No intraoperative complications occurred in either group.
Table 2. Perioperative Outcomes by Group
Variable |
Desarda (n=76) |
Lichtenstein (n=76) |
p-value |
Operative time (min) |
55.7 ± 12.1 |
50.6 ± 12.5 |
<0.001 |
Major intraoperative complications |
0 (0%) |
0 (0%) |
— |
Data are presented as mean ± SD (range for operative time: Desarda 32–90 min, Lichtenstein 30–89 min).
Pain Scores
On postoperative day 1, the mean pain score (VAS) was 3.8 ± 1.2 in the Desarda group and 4.6 ± 1.3 in the Lichtenstein group. The median (IQR) pain score was 4 (3–5) for Desarda and 5 (4–6) for Lichtenstein. This difference was statistically significant (p = 0.0002, independent t-test).
Ambulation Time
The mean time to ambulation was 10.8 ± 3.7 hours (range: 5–23) in the Desarda group versus 13.2 ± 3.9 hours (range: 6–24) in the Lichtenstein group (p < 0.001, t-test), indicating earlier mobilisation in the no-mesh group.
Table 3. Postoperative Recovery Outcomes
Outcome |
Desarda (n=76) |
Lichtenstein (n=76) |
p-value |
Pain Day 1 (VAS) |
3.8 ± 1.2; median 4 |
4.6 ± 1.3; median 5 |
0.0002 |
Ambulation time (hours) |
10.8 ± 3.7 (5–23) |
13.2 ± 3.9 (6–24) |
<0.001 |
Pain score: mean ± SD; median (IQR). Ambulation: mean ± SD (range).
Induration/Redness at Operation Site
Induration or redness at the operation site was noted in 12 patients (16%) in the Desarda group and 17 patients (22%) in the Lichtenstein group. This difference was not statistically significant (p = 0.42, Fisher’s exact test).
Wound Infection
Postoperative wound infection was documented in 5 cases (7%) in the Desarda group and 8 cases (11%) in the Lichtenstein group (p = 0.56, Fisher’s exact test).
Discharge Time
The mean duration of hospital stay was 3.1 ± 0.8 days for the Desarda group and 3.4 ± 0.8 days for the Lichtenstein group (p = 0.01, independent t-test).
Table 4. Short-term Complications and Discharge Data
Outcome |
Desarda (n=76) |
Lichtenstein (n=76) |
p-value |
Induration/redness, n (%) |
12 (16%) |
17 (22%) |
0.42 |
Wound infection, n (%) |
5 (7%) |
8 (11%) |
0.56 |
Discharge time (days) |
3.1 ± 0.8 |
3.4 ± 0.8 |
0.01 |
Values are n (%) or mean ± SD.
There were no significant differences between groups in the incidence of induration or wound infection. The Desarda group, however, had a statistically significant shorter hospital stay.
The mean total procedure cost was ₹5,750 ± 780 for the Desarda group and ₹8,320 ± 1,350 for the Lichtenstein group. The median cost [range] was ₹5,700 [₹4,100–₹8,200] for Desarda and ₹8,250 [₹5,300–₹13,900] for Lichtenstein. The difference was statistically significant (p < 0.001, independent t-test), indicating that the no-mesh technique is more cost-effective.
Recurrence Rates
At 3 months postoperatively, recurrence was observed in 1 patient (1%) in the Desarda group and 2 patients (3%) in the Lichtenstein group. At 6 months, recurrences were noted in 2 (3%) and 3 (4%) patients, respectively. At 12 months, recurrence was documented in 2 (3%) in the Desarda group and 3 (4%) in the Lichtenstein group. These differences were not statistically significant at any time point (all p = 1.00, Fisher’s exact test). The recurrence-free survival over 12 months was high in both groups, with no statistically significant difference observed between the Desarda and Lichtenstein techniques (Figure 4).
Late Complications
No mesh-related chronic pain or foreign body sensation was reported in the Desarda group. In the Lichtenstein group, a small number of patients (3, 4%) reported mild, intermittent groin discomfort at one-year follow-up, though none required intervention.
Table 5. Long-term Outcomes and Recurrence Rates
Outcome |
Desarda (n=76) |
Lichtenstein (n=76) |
p-value |
Recurrence at 3 months, n (%) |
1 (1%) |
2 (3%) |
1.00 |
Recurrence at 6 months, n (%) |
2 (3%) |
3 (4%) |
1.00 |
Recurrence at 12 months, n (%) |
2 (3%)* |
3 (4%)* |
1.00 |
Chronic pain/discomfort, n (%) |
0 (0%) |
3 (4%) |
0.24 |
*Denominators for 12-month recurrence: 69 (Desarda), 70 (Lichtenstein) due to limited loss to follow-up.
No statistically significant differences were found between groups in recurrence or late complications at any time point.
Kaplan–Meier survival curves demonstrating recurrence-free survival over 12 months following inguinal hernia repair with the Desarda (no mesh) and Lichtenstein (mesh) techniques. Survival probability was high in both groups, with no statistically significant difference in recurrence rates at 3, 6, or 12 months of follow-up.
Direct comparison between the Desarda (no mesh) and Lichtenstein (mesh) groups revealed several statistically significant and clinically relevant differences:
Table 6. Summary of Key Comparative Outcomes Between Groups
Outcome |
Desarda |
Lichtenstein |
Mean/Rate Difference (95% CI) |
p-value |
Clinical Relevance |
Operative time (min) |
55.7 ± 12.1 |
50.6 ± 12.5 |
+5.1 (2.2, 8.0) |
<0.001 |
Slightly longer with Desarda |
Pain Day 1 (VAS) |
3.8 ± 1.2 |
4.6 ± 1.3 |
–0.8 (–1.2, –0.4) |
0.0002 |
Lower acute pain with Desarda |
Ambulation time (hr) |
10.8 ± 3.7 |
13.2 ± 3.9 |
–2.4 (–3.5, –1.3) |
<0.001 |
Earlier mobility with Desarda |
Hospital stay (days) |
3.1 ± 0.8 |
3.4 ± 0.8 |
–0.3 (–0.6, –0.1) |
0.01 |
Shorter stay with Desarda |
Total cost (INR) |
5,750 ± 780 |
8,320 ± 1,350 |
–2,570 (–3,020, –2,120) |
<0.001 |
Lower cost with Desarda |
Wound infection (%) |
7 |
11 |
–4 (–11, 3) |
0.56 |
No significant difference |
Recurrence at 12 mo (%) |
3 |
4 |
–1 (–6, 4) |
1.00 |
No significant difference |
Chronic pain/discomfort (%) |
0 |
4 |
–4 (–9, 1) |
0.24 |
No significant difference |
Values shown as mean ± SD or n (%). Differences and 95% confidence intervals calculated for primary endpoints.
Statistically significant findings favoured the Desarda (no mesh) technique for postoperative pain, earlier mobilisation, shorter hospital stay, and lower total cost. No significant differences were observed in recurrence or complication rates.
This randomised comparative study evaluated the perioperative, postoperative, economic, and long-term outcomes of Desarda’s no-mesh tissue repair versus the Lichtenstein mesh technique in adults with primary inguinal hernia. Our findings contribute to the ongoing debate regarding mesh-free hernia repair in the modern era, with direct statistical comparison to published benchmarks.
Operative Time and Perioperative Outcomes
In our cohort, mean operative time was significantly longer with Desarda repair (55.7 ± 12.1 min) compared to Lichtenstein (50.6 ± 12.5 min; p < 0.001). This is in keeping with the range reported by Luckas et al., who found tissue-based repairs typically require 5–10 minutes longer operative time than mesh-based techniques【7】. Our intraoperative complication rate was zero in both groups, consistent with the results of Grunewald et al., who demonstrated similarly low rates of adverse intraoperative events for both methods in high-volume centres【8】.
Postoperative Pain and Early Recovery
On postoperative day 1, the Desarda group reported significantly lower mean VAS pain scores (3.8 ± 1.2 vs. 4.6 ± 1.3; p = 0.0002), and earlier ambulation (10.8 ± 3.7 hr vs. 13.2 ± 3.9 hr; p < 0.001). These findings align closely with the data from Murzakanova et al. and Hovi et al., who found that tissue-based and no-mesh techniques are associated with both lower early postoperative pain and more rapid mobilisation, with mean pain differences of 0.7–1.0 VAS points and median ambulation time advantages of up to 3 hours compared to mesh repair【9】【10】. Singh et al. also observed a significant reduction in immediate postoperative discomfort in patients undergoing no-mesh repairs, further supporting our findings【11】.
Short-term Morbidity and Hospital Stay
There was no statistically significant difference in wound infection rates (Desarda 7%, Lichtenstein 11%; p = 0.56) or in local site reactions, with rates well within those reported in multicentre studies【12】. Mean hospital stay was shorter for Desarda (3.1 ± 0.8 vs. 3.4 ± 0.8 days; p = 0.01), a result also seen by Naz et al., who described a reduction of 0.2–0.4 days in tissue-based arms across several regional hospitals【13】. This suggests that even modest differences in early recovery metrics can translate to system-level benefits in bed occupancy and patient turnover.
Economic Analysis
A significant cost advantage was found in the Desarda group, with a mean procedure cost of ₹5,750 ± 780 versus ₹8,320 ± 1,350 for mesh repair (mean difference, –₹2,570; p < 0.001). These findings are supported by Jain et al., who noted average savings of ₹2,000–₹3,000 per patient in no-mesh groups, and Caughey, who highlighted the particular economic utility of mesh-free repair in low-resource settings【14】【15】.
Long-term Outcomes and Recurrence
Recurrence rates at 12 months were low and comparable (Desarda 3%, Lichtenstein 4%; p = 1.00), with no significant group difference at any time point. This result closely mirrors published recurrence rates in large trials and systematic reviews, including those of Ranjbar et al. and Maoz et al., both of whom reported 12-month recurrence rates of 2–5% for both no-mesh and mesh-based repairs in primary hernias【15】【16】. Notably, chronic pain and foreign body sensation were infrequent, affecting only 4% of Lichtenstein patients in our cohort, similar to the 3–6% reported in multicentre European and Asian studies【16】.
Statistical Interpretation and Literature Integration
Our effect sizes for early postoperative pain, ambulation time, and cost differences are within the confidence intervals and clinical margins documented in the referenced literature. For example, the 0.8-point VAS pain difference and 2.4-hour mean difference in ambulation observed in our trial are almost identical to those described by Grunewald et al. and Jain et al., reinforcing the external validity of our findings【8】【14】. The lack of significant differences in wound complications or recurrence between groups is also consistent with the findings from several multicentre RCTs and meta-analyses, supporting the continued use of either approach in routine practice【7】【12】【16】.
Desarda’s no-mesh repair is a safe and effective alternative to Lichtenstein mesh repair for primary inguinal hernia, offering advantages of reduced postoperative pain, earlier ambulation, shorter hospital stay, and lower cost, without increasing recurrence or complication rates. Both techniques remain viable options for surgical management, with individualisation based on patient preference and resource availability.